-
Something wrong with this record ?
Transcranial sonography of the substantia nigra: digital image analysis
D. Skoloudík, M. Jelínková, J. Blahuta, P. Cermák, T. Soukup, P. Bártová, K. Langová, R. Herzig,
Language English Country United States
Document type Journal Article, Research Support, Non-U.S. Gov't
PubMed
25059698
DOI
10.3174/ajnr.a4049
Knihovny.cz E-resources
- MeSH
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Brain Stem ultrasonography MeSH
- Parkinson Disease ultrasonography MeSH
- Image Processing, Computer-Assisted * MeSH
- Aged MeSH
- Temporal Bone ultrasonography MeSH
- Substantia Nigra ultrasonography MeSH
- Ultrasonography, Doppler, Transcranial * MeSH
- Healthy Volunteers MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
BACKGROUND AND PURPOSE: Increased echogenicity of the substantia nigra is a typical transcranial sonography finding in Parkinson disease. Experimental software for digital analysis of the echogenic substantia nigra area has been developed. The aim of this study was to compare the evaluation of substantia nigra echogenicity by using digital analysis with a manual measurement in patients with Parkinson disease and healthy volunteers. MATERIALS AND METHODS: One hundred thirteen healthy volunteers were enrolled in the derivation cohort, and 50 healthy volunteers and 30 patients with Parkinson disease, in the validation cohort. The substantia nigra was imaged from the right and left temporal bone window by using transcranial sonography. All subjects were examined twice by using different sonographic machines by an experienced sonographer. DICOM images of the substantia nigra were encoded; then, digital analysis and manual measurement of the substantia nigra were performed. The 90th percentile of the derivation cohort values was used as a cut-point for the evaluation of the hyperechogenic substantia nigra in the validation cohort. The Spearman coefficient was used for assessment of the correlation between both measurements. The Cohen κ coefficient was used for the assessment of the correlation between both measurements and Parkinson disease diagnosis. RESULTS: The Spearman coefficient between measurements by using different machines was 0.686 for digital analysis and 0.721 for manual measurement (P < .0001). Hyperechogenic substantia nigra was detected in the same 26 (86.7%) patients with Parkinson disease by using both measurements. Cohen κ coefficients for digital analysis and manual measurement were 0.787 and 0.762, respectively (P < .0001). CONCLUSIONS: The present study showed comparable results when measuring the substantia nigra features conventionally and by using the developed software.
Department of Neurology Hospital Karviná Ráj Karviná Czech Republic
Department of Neurology University Hospital Ostrava Ostrava Czech Republic
From the Faculty of Health Science University Hospital Ostrava Ostrava Czech Republic
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc16000687
- 003
- CZ-PrNML
- 005
- 20160121114242.0
- 007
- ta
- 008
- 160108s2014 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3174/ajnr.A4049 $2 doi
- 035 __
- $a (PubMed)25059698
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Skoloudík, D $u From the Faculty of Health Science (D.Š.), Palacký University Olomouc, Olomouc, Czech Republic Department of Neurology (D.Š., M.J., P.B.), University Hospital Ostrava, Ostrava, Czech Republic skoloudik@hotmail.com.
- 245 10
- $a Transcranial sonography of the substantia nigra: digital image analysis / $c D. Skoloudík, M. Jelínková, J. Blahuta, P. Cermák, T. Soukup, P. Bártová, K. Langová, R. Herzig,
- 520 9_
- $a BACKGROUND AND PURPOSE: Increased echogenicity of the substantia nigra is a typical transcranial sonography finding in Parkinson disease. Experimental software for digital analysis of the echogenic substantia nigra area has been developed. The aim of this study was to compare the evaluation of substantia nigra echogenicity by using digital analysis with a manual measurement in patients with Parkinson disease and healthy volunteers. MATERIALS AND METHODS: One hundred thirteen healthy volunteers were enrolled in the derivation cohort, and 50 healthy volunteers and 30 patients with Parkinson disease, in the validation cohort. The substantia nigra was imaged from the right and left temporal bone window by using transcranial sonography. All subjects were examined twice by using different sonographic machines by an experienced sonographer. DICOM images of the substantia nigra were encoded; then, digital analysis and manual measurement of the substantia nigra were performed. The 90th percentile of the derivation cohort values was used as a cut-point for the evaluation of the hyperechogenic substantia nigra in the validation cohort. The Spearman coefficient was used for assessment of the correlation between both measurements. The Cohen κ coefficient was used for the assessment of the correlation between both measurements and Parkinson disease diagnosis. RESULTS: The Spearman coefficient between measurements by using different machines was 0.686 for digital analysis and 0.721 for manual measurement (P < .0001). Hyperechogenic substantia nigra was detected in the same 26 (86.7%) patients with Parkinson disease by using both measurements. Cohen κ coefficients for digital analysis and manual measurement were 0.787 and 0.762, respectively (P < .0001). CONCLUSIONS: The present study showed comparable results when measuring the substantia nigra features conventionally and by using the developed software.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a mozkový kmen $x ultrasonografie $7 D001933
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a zdraví dobrovolníci pro lékařské studie $7 D064368
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a počítačové zpracování obrazu $7 D007091
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a Parkinsonova nemoc $x ultrasonografie $7 D010300
- 650 _2
- $a substantia nigra $x ultrasonografie $7 D013378
- 650 _2
- $a spánková kost $x ultrasonografie $7 D013701
- 650 12
- $a ultrasonografie dopplerovská transkraniální $7 D017585
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Jelínková, M $u Department of Neurology (D.Š., M.J., P.B.), University Hospital Ostrava, Ostrava, Czech Republic Department of Neurology (M.J.), Hospital, Karviná-Ráj, Karviná, Czech Republic.
- 700 1_
- $a Blahuta, J $u Institute of Computer Science (J.B., P.Č., T.S.), Faculty of Philosophy and Science, Silesian University in Opava, Opava, Czech Republic.
- 700 1_
- $a Cermák, P $u Institute of Computer Science (J.B., P.Č., T.S.), Faculty of Philosophy and Science, Silesian University in Opava, Opava, Czech Republic.
- 700 1_
- $a Soukup, T $u Institute of Computer Science (J.B., P.Č., T.S.), Faculty of Philosophy and Science, Silesian University in Opava, Opava, Czech Republic.
- 700 1_
- $a Bártová, P $u Department of Neurology (D.Š., M.J., P.B.), University Hospital Ostrava, Ostrava, Czech Republic.
- 700 1_
- $a Langová, K $u Department of Biophysics (K.L.), Faculty of Medicine and Dentistry, Institute of Molecular and Translational Medicine, Palacký University, Olomouc, Czech Republic.
- 700 1_
- $a Herzig, R $u Department of Neurology (R.H.), Charles University Faculty of Medicine and University Hospital Hradec Králové, Hradec Králové, Czech Republic.
- 773 0_
- $w MED00009116 $t AJNR. American journal of neuroradiology $x 1936-959X $g Roč. 35, č. 12 (2014), s. 2273-8
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/25059698 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20160108 $b ABA008
- 991 __
- $a 20160121114402 $b ABA008
- 999 __
- $a ok $b bmc $g 1102968 $s 924893
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2014 $b 35 $c 12 $d 2273-8 $e 20140724 $i 1936-959X $m American journal of neuroradiology $n AJNR Am J Neuroradiol $x MED00009116
- LZP __
- $a Pubmed-20160108